StockData

Dianthus Therapeutics, Inc. (DNTH) stock

DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$86.98−2.57 (-2.87%)

Close on Nov 17, 2026Market cap $4.87BP/E –Yield 0.00%

Dianthus Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Dianthus Therapeutics's price to sales ratio was 231.9× on Oct 31, 2025, against 198.6× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 2025231.9×+112.6
2024Dec 31, 2024119.3×–

More Dianthus Therapeutics figures

See a number that looks wrong?